Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects
Hong Jiang,1,* Zhi-Peng Li,1,* Gui-Xiang Tian,1,* Rui-Yan Pan,1 Chong-Mei Xu,2 Bo Zhang,2 Jing-liang Wu1 1School of Bioscience and Technology, Weifang Medical University, Weifang, Shandong, China; 2School of Pharmacy, Weifang Medical University, Weifang, Shandong, China *These authors contributed...
Main Authors: | Jiang H, Li ZP, Tian GX, Pan RY, Xu CM, Zhang B, Wu JL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-03-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/liver-targeted-liposomes-for-codelivery-of-curcumin-and-combretastatin-peer-reviewed-article-IJN |
Similar Items
-
Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy
by: Gu Y, et al.
Published: (2019-11-01) -
Early Effects of Combretastatin-A4 Disodium Phosphate on Tumor Perfusion and Interstitial Fluid Pressure
by: Carsten D. Ley, et al.
Published: (2007-02-01) -
Combretastatins D series and analogues: from isolation, synthetic challenges and biological activities
by: Jorge de Lima Neto, et al.
Published: (2023-03-01) -
Molecular docking of combretastatin derivatives to combat human cancer cells
by: Kshitij Chitnis, et al.
Published: (2024-01-01) -
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent
by: Celina de Jesus Guimarães, et al.
Published: (2023-04-01)